Pharmacokinetics and Pharmacodynamics of Ropeginterferon Alfa-2b in Healthy Japanese and Caucasian Subjects After Single Subcutaneous Administration
Narihisa Miyachi, Oleh Zagrijtschuk, Lisa Kang, Katsuya Yonezu, Albert Qin
Topics & Concepts
MedicinePharmacokineticsPharmacodynamicsTolerabilityCohortInternal medicineDosingBioequivalenceGastroenterologyPharmacologyAdverse effectMyeloproliferative Neoplasms: Diagnosis and TreatmentCytokine Signaling Pathways and Interactionsinterferon and immune responses